Guardant Health, Inc.GHNASDAQ
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank89
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
-38.08%
↑ 57% vs avg
Percentile
P89
Within normal range
Streak
3 yr
Consecutive growthExpanding
Average
-89.57%
Historical baseline
PeriodValueYoY Change
2025-38.08%+27.9%
2024-52.79%+31.3%
2023-76.83%+43.8%
2022-136.79%-42.1%
2021-96.24%-22.6%
2020-78.50%-206.3%
2019-25.62%+69.4%
2018-83.67%+44.6%
2017-151.09%+3.2%
2016-156.13%-